Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.23 (
MMP
)
4,246
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Signal-induced proliferation-associated protein 1
(
SIPA1
) is known to be a GTPase activating protein. Overexpressed
SIPA1
is related to metastatic progression in breast and prostate cancers; however, the relevance of
SIPA1
in oral squamous cell carcinoma (OSCC) is still unknown. The aim of this study was to examine
SIPA1
expression and its functional mechanisms in OSCC.
SIPA1
mRNA and protein expressions were analyzed by quantitative reverse transcriptase-polymerase chain reaction, Western blot analysis, and immunohistochemistry. The expressions of
SIPA1
were up-regulated significantly in vitro and in vivo. Moreover,
SIPA1
expression was correlated with regional lymph node metastasis. We next assessed the cellular functions associated with tumoral metastasis using
SIPA1
knockdown (shSIPA1) cells and analyzed the downstream molecules of
SIPA1
, i.e., bromodomain containing protein 4(BRD4), integrin beta1 (ITGB1), and matrix metalloproteinase 7 (MMP7). The shSIPA1 cells showed decreased invasiveness and migratory activities, however cellular adhesion ability was maintained at a high level. In addition, ITGB1 expression was greater in shSIPA1 cells, whereas
MMP7
expression was lower than in control cells. This research is the first to establish that
SIPA1
promotes cancer metastasis by regulating the ITGB1 and
MMP7
. Therefore,
SIPA1
might be a novel therapeutic target for patients with lymph node metastasis of OSCC.
...
PMID:SIPA1 promotes invasion and migration in human oral squamous cell carcinoma by ITGB1 and MMP7. 2823 46